<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04028648</url>
  </required_header>
  <id_info>
    <org_study_id>BCA-12</org_study_id>
    <nct_id>NCT04028648</nct_id>
  </id_info>
  <brief_title>Generation of Prediction Equations for BIA of the Elderly</brief_title>
  <official_title>Generation of Prediction Equations to Analyze Body Composition of the Elderly Based on Bioelectrical Impedance Analysis (BIA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seca GmbH &amp; Co. Kg.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seca GmbH &amp; Co. Kg.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to develop prediction equations for calculating Fat-Free Mass
      FFM, Total Body Water TBW, Extracellular Water ECW, Visceral Adipose Tissue VAT, total
      Skeletal Muscle Mass SMM and segmental SMM in a group of elderly. The prediction equations
      are based on linear regression analysis between the gold standard reference methods Air
      Displacement Plethysmography ADP, Dual-energy X-ray Absorptiometry DXA, Magnet Resonance
      Imaging MRI, Deuterium dilution method (D2O) and Sodium Bromide dilution method (NaBr) on the
      one hand and bioelectrical impedance measurements on the other hand.

      Multi-frequency bioimpedance is measured for all body segments: right arm, left arm, right
      leg, left leg, trunk, right body side and left body side using the seca mBCA 515 in standing
      position and the seca mBCA 525 in standing and lying position.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2019</start_date>
  <completion_date type="Anticipated">February 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BIA 5 and 50 kHz</measure>
    <time_frame>15 minutes</time_frame>
    <description>Bioelectrical Impedance of 5 and 50 kHz for one body side</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BIA 50 kHz</measure>
    <time_frame>15 minutes</time_frame>
    <description>Bioelectrical Impedance of 50 kHz for all 4 extremities</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total body water</measure>
    <time_frame>15 minutes</time_frame>
    <description>Total body water (TBW) by deuterium (D2O) dilution</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Extracellular water</measure>
    <time_frame>15 minutes</time_frame>
    <description>Extracellular water (ECW) by NaBr dilution</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fat-free mass</measure>
    <time_frame>1hour</time_frame>
    <description>Fat-free mass by a 4-compartment model based on dual energy x-ray absorption (DXA), air displacement plethysmography (ADP), D2O dilution and weight</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skeletal muscle mass</measure>
    <time_frame>1 hour</time_frame>
    <description>Skeletal muscle mass (SMM) by magnetic resonance imaging (MRI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visceral adipose tissue</measure>
    <time_frame>1 hour</time_frame>
    <description>Visceral adipose tissue (VAT) by magnetic resonance imaging MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete BIA</measure>
    <time_frame>15 minutes</time_frame>
    <description>Bioelectrical Impedance of 1, 1.5, 2, 3, 7.5, 10, 15, 20, 30, 75, 100, 150, 200, 300, 500, 750 and 1,000 kHz for all body segments: right arm, left arm, right leg, left leg, trunk, right body side and left body side.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Healthy Elderly</condition>
  <arm_group>
    <arm_group_label>elderly</arm_group_label>
    <description>150 elderlies (&gt;60 years): community dwelling or living in old</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        150 elderlies (&gt;60 years): community dwelling or living in old nursing homes
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female subjects older than 60 years,

          -  stable medication (no changes during the past 6 months),

          -  subjects need to be able to sign the informed consent and privacy policy

        Exclusion Criteria:

          -  acute disease

          -  intake of diuretics

          -  wearing of support stockings

          -  edema diagnosed by inspection and palpation of lower limbs

          -  paralysis e.g. after a stroke

          -  neurodegenerative diseases e.g. ALS

          -  tumors in treatment

          -  amputation

          -  electronic implants e.g. pacemaker

          -  under the skin applied injection systems (e.g. insulin pumps or pain pumps)

          -  probands who cannot provide an ICF by themselves

          -  probands who might be dependent from the sponsor or the investigation site

          -  current alcohol abuse

          -  active prostheses

          -  electronic life-support systems, e.g. artificial heart, artificial lung

          -  portable electronic medical devices, e.g. ECG devices or infusion pumps

          -  metallic implants

          -  cochlea implants und heart valves prothesis (e.g. Starr-Edwards-Prothesis)

          -  vessel clips in the brain or medulla applied before 1995

          -  defeatable pumps

          -  catheter

          -  iron or metallic parts in the body (e.g. shard of metal)

          -  dental braces

          -  magnetic tooth implants

          -  not removeable piercings

          -  extensive tattoos
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kristin Kl√ºckmann</last_name>
    <phone>+4940200000</phone>
    <phone_ext>232</phone_ext>
    <email>Kristin.Klueckmann@seca.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Human Nutrition and Food Science</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Bosy-Westphal, Prof. Dr. Dr.</last_name>
      <phone>0049 431 880</phone>
      <phone_ext>5670</phone_ext>
      <email>abosyw@nutrfoodsc.uni-kiel.de</email>
    </contact>
    <investigator>
      <last_name>Anja Bosy-Westphal, Prof. Dr. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wiebke Braun, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>September 14, 2018</study_first_submitted>
  <study_first_submitted_qc>July 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2019</study_first_posted>
  <last_update_submitted>July 19, 2019</last_update_submitted>
  <last_update_submitted_qc>July 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

